Do analysts recommend HSCS or FLGC?

HeartSciences currently has a consensus price target of $8.00, suggesting a potential upside of 135.99%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is HSCS or FLGC more profitable?

HeartSciences has a net margin of 0.00% compared to Flora Growth's net margin of -32.03%. Flora Growth's return on equity of -64.02% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -358.60% -144.82% Flora Growth -32.03% -64.02% -34.46%

Do analysts rate TMDIF or FLGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer FLGC or ICU?

SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 164.03%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts plainly believe SeaStar Medical is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend FLGC or ADGM?

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 523.89%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Flora Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Flora Growth (FLGC) Competitors

$4.84 -0.06 (-1.22%)

As of 09/11/2026

Compare

FLGC vs. HSCS, TMDIF, NMTC, ICU, and ADGM

Should you buy Flora Growth stock or one of its competitors? Flora Growth's main competitors and comparable companies include HeartSciences (HSCS), Titan Medical (TMDIF), NeuroOne Medical Technologies (NMTC), SeaStar Medical (ICU), and Adagio Medical (ADGM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Flora Growth compare to HeartSciences?

HeartSciences (NASDAQ:HSCS) and Flora Growth (NASDAQ:FLGC) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

HeartSciences currently has a consensus price target of $8.00, suggesting a potential upside of 135.99%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, HeartSciences had 3 more articles in the media than Flora Growth. MarketBeat recorded 3 mentions for HeartSciences and 0 mentions for Flora Growth. HeartSciences' average media sentiment score of 0.29 beat Flora Growth's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Overall Sentiment
HeartSciences	Neutral
Flora Growth	Neutral

HeartSciences has a beta of 1.85, indicating that its stock price is 85% more volatile than the broader market. Comparatively, Flora Growth has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

HeartSciences has higher earnings, but lower revenue than Flora Growth. HeartSciences is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A

HeartSciences has a net margin of 0.00% compared to Flora Growth's net margin of -32.03%. Flora Growth's return on equity of -64.02% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Flora Growth	-32.03%	-64.02%	-34.46%

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Comparatively, 2.3% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

HeartSciences beats Flora Growth on 9 of the 15 factors compared between the two stocks.

How does Flora Growth compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Flora Growth (NASDAQ:FLGC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Flora Growth'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Flora Growth	Neutral

Titan Medical has higher earnings, but lower revenue than Flora Growth. Flora Growth is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.78	$6.95M	$0.05	2.41
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Comparatively, 2.3% of Flora Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Titan Medical has a net margin of 0.00% compared to Flora Growth's net margin of -32.03%. Flora Growth's return on equity of -64.02% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Flora Growth	-32.03%	-64.02%	-34.46%

Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Flora Growth has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Flora Growth beats Titan Medical on 7 of the 12 factors compared between the two stocks.

How does Flora Growth compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Flora Growth (NASDAQ:FLGC) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

In the previous week, NeuroOne Medical Technologies had 5 more articles in the media than Flora Growth. MarketBeat recorded 5 mentions for NeuroOne Medical Technologies and 0 mentions for Flora Growth. NeuroOne Medical Technologies' average media sentiment score of 1.19 beat Flora Growth's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
NeuroOne Medical Technologies	Positive
Flora Growth	Neutral

NeuroOne Medical Technologies presently has a consensus target price of $7.33, suggesting a potential upside of 370.09%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe NeuroOne Medical Technologies is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Comparatively, 2.3% of Flora Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

NeuroOne Medical Technologies has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market. Comparatively, Flora Growth has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market.

Flora Growth has a net margin of -32.03% compared to NeuroOne Medical Technologies' net margin of -71.50%. Flora Growth's return on equity of -64.02% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-71.50%	-128.12%	-86.34%
Flora Growth	-32.03%	-64.02%	-34.46%

NeuroOne Medical Technologies has higher earnings, but lower revenue than Flora Growth. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	1.17	-$3.61M	-$0.95	N/A
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A

Summary

NeuroOne Medical Technologies beats Flora Growth on 9 of the 16 factors compared between the two stocks.

How does Flora Growth compare to SeaStar Medical?

Flora Growth (NASDAQ:FLGC) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

36.0% of Flora Growth shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 2.3% of Flora Growth shares are held by insiders. Comparatively, 0.7% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 164.03%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts plainly believe SeaStar Medical is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Flora Growth has a net margin of -32.03% compared to SeaStar Medical's net margin of -795.51%. Flora Growth's return on equity of -64.02% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
SeaStar Medical	-795.51%	-162.75%	-109.89%

SeaStar Medical has lower revenue, but higher earnings than Flora Growth. SeaStar Medical is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
SeaStar Medical	$1.23M	10.86	-$12.15M	-$3.91	N/A

In the previous week, SeaStar Medical had 2 more articles in the media than Flora Growth. MarketBeat recorded 2 mentions for SeaStar Medical and 0 mentions for Flora Growth. SeaStar Medical's average media sentiment score of 0.93 beat Flora Growth's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Flora Growth	Neutral
SeaStar Medical	Positive

Flora Growth has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market.

Summary

Flora Growth and SeaStar Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Flora Growth compare to Adagio Medical?

Flora Growth (NASDAQ:FLGC) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

Flora Growth has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Flora Growth	$57.61M	0.09	-$15.91M	-$32.49	N/A
Adagio Medical	$600K	20.77	-$25.08M	-$1.48	N/A

In the previous week, Adagio Medical had 1 more articles in the media than Flora Growth. MarketBeat recorded 1 mentions for Adagio Medical and 0 mentions for Flora Growth. Adagio Medical's average media sentiment score of 1.87 beat Flora Growth's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Flora Growth	Neutral
Adagio Medical	Very Positive

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 523.89%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Flora Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Flora Growth	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

36.0% of Flora Growth shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 2.3% of Flora Growth shares are held by insiders. Comparatively, 7.8% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Adagio Medical has a net margin of 0.00% compared to Flora Growth's net margin of -32.03%. Flora Growth's return on equity of -64.02% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Flora Growth	-32.03%	-64.02%	-34.46%
Adagio Medical	N/A	-661.85%	-73.35%

Flora Growth has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market.

Summary

Adagio Medical beats Flora Growth on 10 of the 16 factors compared between the two stocks.

Get Flora Growth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FLGC vs. The Competition

Export

Metric	Flora Growth	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$9.36M	$5.48B	$7.16B	$12.85B
Dividend Yield	N/A	1.79%	2.57%	11.71%
P/E Ratio	-0.15	25.09	274.94	25.36
Price / Sales	0.09	71.54	685.45	111.82
Price / Cash	N/A	32.57	76.65	51.52
Price / Book	0.40	5.97	10.33	6.20
Net Income	-$15.91M	$150.75M	$3.50B	$358.50M
7 Day Performance	12.56%	-2.83%	-3.32%	-2.35%
1 Month Performance	164.48%	-3.73%	-0.53%	-3.23%
1 Year Performance	-79.85%	9.38%	23.51%	8.79%

Flora Growth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FLGC Flora Growth	0.1206 of 5 stars	$4.84 -1.2%	N/A	-79.8%	$9.36M	$57.61M	N/A	280	High Trading Volume
HSCS HeartSciences	2.1842 of 5 stars	$3.99 -2.3%	$8.00 +100.8%	+12.6%	$15.54M	$4.32K	N/A	10	Analyst Upgrade Short Interest Increase
TMDIF Titan Medical	N/A	$0.13 +2.0%	N/A	-66.8%	$14.98M	$17.63M	N/A	50	Gap Down
NMTC NeuroOne Medical Technologies	3.6293 of 5 stars	$1.64 -3.3%	$7.33 +348.5%	-70.8%	$14.90M	$12.10M	N/A	20	Positive News Short Interest Increase
ICU SeaStar Medical	3.3002 of 5 stars	$3.08 +4.4%	$8.00 +159.7%	-65.2%	$13.57M	$1.71M	N/A	2	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FLGC) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Flora Growth (FLGC) Competitors

FLGC vs. HSCS, TMDIF, NMTC, ICU, and ADGM

How does Flora Growth compare to HeartSciences?

Summary

How does Flora Growth compare to Titan Medical?

Summary

How does Flora Growth compare to NeuroOne Medical Technologies?

Summary

How does Flora Growth compare to SeaStar Medical?

Summary

How does Flora Growth compare to Adagio Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGC vs. The Competition

Flora Growth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Flora Growth (FLGC) Competitors

FLGC vs. HSCS, TMDIF, NMTC, ICU, and ADGM

How does Flora Growth compare to HeartSciences?

Do analysts recommend HSCS or FLGC?

Does the media refer more to HSCS or FLGC?

Which has more risk and volatility, HSCS or FLGC?

Which has preferable earnings and valuation, HSCS or FLGC?

Is HSCS or FLGC more profitable?

Do institutionals and insiders believe in HSCS or FLGC?

Summary

How does Flora Growth compare to Titan Medical?

Does the media favor TMDIF or FLGC?

Which has better earnings and valuation, TMDIF or FLGC?

Do institutionals and insiders believe in TMDIF or FLGC?

Is TMDIF or FLGC more profitable?

Which has more volatility and risk, TMDIF or FLGC?

Do analysts rate TMDIF or FLGC?

Summary

How does Flora Growth compare to NeuroOne Medical Technologies?

Does the media favor NMTC or FLGC?

Do analysts recommend NMTC or FLGC?

Do institutionals & insiders hold more shares of NMTC or FLGC?

Which has more volatility & risk, NMTC or FLGC?

Is NMTC or FLGC more profitable?

Which has preferable earnings and valuation, NMTC or FLGC?

Summary

How does Flora Growth compare to SeaStar Medical?

Do institutionals and insiders have more ownership in FLGC or ICU?

Do analysts prefer FLGC or ICU?

Is FLGC or ICU more profitable?

Which has better earnings & valuation, FLGC or ICU?

Does the media refer more to FLGC or ICU?

Which has more volatility & risk, FLGC or ICU?

Summary

How does Flora Growth compare to Adagio Medical?

Which has preferable earnings & valuation, FLGC or ADGM?

Does the media refer more to FLGC or ADGM?

Do analysts recommend FLGC or ADGM?

Do institutionals and insiders have more ownership in FLGC or ADGM?

Is FLGC or ADGM more profitable?

Which has more risk and volatility, FLGC or ADGM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FLGC vs. The Competition

Flora Growth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools